In contrast, pretreatment of MM cell-resistant cells with bafilomycinA1 (Baf), a mitophagy inhibitor, re-sensitized NCI-H929R, and RPMI8266-R5 cells to BTZ (Figure S3E). Here, CASC3 is linked to Miyoshi myopathy.